Milestones of SAMLY
From June 3rd to June 4th, city level leaders Mr. Tang Jun, Mr. Jiang Debao, and a team of review experts; Director Liu Hongming, Director Du Haitao, Deputy Director Jin Peng, Director Zhou Qianjin, and Director Jia Qingchao, leaders of the provincial, municipal, and county market supervision bureaus, conducted on-site audits of the food and health food production license renewal at the Jiangsu factory of SAMLY.
Recently, SAMLY has reached a formal cooperation agreement with the Revision Pharmaceutical Group, authorizing SAMLY to act as an agent for the revision of all imported food, health food and other products in the China region, and entrusting SAMLY to produce strong products such as vitamin E.
On November 22nd, Shenzhen Zhengyi Cheng Medical Technology Co., Ltd., the new project development center established by SAMLY and Correction Pharmaceutical in the south, officially launched operations as the "bridgehead for correcting southern sales"! The project center will comprehensively focus on cooperation matters such as product selection, product market positioning, and layout, and develop and implement a scientifically sound project cooperation plan.
On the morning of September 30, 2021, Xu Guangliang, the county magistrate of Shuyang County, Jiangsu Province, along with Jin Tao, the deputy director of Suqian Customs, Jiang Jie, the deputy director of Suqian Customs, Sang Xiuhong, the head of Suqian Customs Supervision Department, Bao Yinye, the enterprise management department of Suqian Customs, and other leaders visited the Jiangsu factory to conduct research and guidance, accompanied by General Manager Hua Xiangqian, Deputy General Manager Wang Hengqing, Quality Department Ren Kailai, Production Department Liu Juan, and others, to care about the operation of the enterprise.
From June 3rd to June 4th, city level leaders Mr. Tang Jun, Mr. Jiang Debao, and a team of review experts; Director Liu Hongming, Director Du Haitao, Deputy Director Jin Peng, Director Zhou Qianjin, and Director Jia Qingchao, leaders of the provincial, municipal, and county market supervision bureaus, conducted on-site audits of the food and health food production license renewal at the Jiangsu factory of SAMLY.
Every achievement of the factory is condensed with your sweat, wisdom, and diligence, and every achievement is embedded with your halo.
Standing at this new starting point in 2021, we will have new hope and embark on a new journey together.
Let us all Samly colleagues join hands together, based on infinite friendship and common interests, and move towards a common development goal to achieve greater success.
On March 6, 2021, the "SAMLY Hand in Hand with Hainan Zhendetang Pharmaceutical Investment Promotion Conference" was grandly opened at the Fuyuan Garden Hotel in Haikou!
Mr. Zhang Hua, Marketing Director of Samly, Mr. Zhuang Linfeng, General Manager of Hainan Zhenyu and Zhendetang Pharmaceutical, Mr. Shen Yinyan, General Manager of Hainan Zhonglixin Health Industry, Mr. Lv Chen, Provincial Manager of Samly Hainan, Ms. Zhou Lingzhi, Manager of Samly Training Department, and representatives of some branch stores of Zhendetang Pharmaceutical witnessed this exciting moment together!
The promotion meeting for the Guangdong Enjoyment Plan of Marketing Department 2 was successfully held at Jinhaiwan Villa in Xunliao Bay, Huizhou from January 15th to 17th, 2021.
Mr. Chen Liangchao, Chairman, Mr. Zou Weibing, Marketing Director, Mr. Zhang Hua, Deputy Marketing Director, and some members of Marketing Department 2 attended the meeting.
On December 8, 2020, Sangmei Ni Medical Equipment Co., Ltd., a subsidiary of SAMLY, officially obtained the "Medical Device Production License". Accelerate the new production process of "Class I and II Medical Personnel Protective Equipment" by Sangmei Ni Medical Equipment Co., Ltd!
Mr. Chen Liangchao, Chairman of SAMLY, has always regarded the production of medical devices as an important strategic plan. Under the precise guidance of various levels of government and relevant functional departments, Sanmeni has invested a large amount of manpower, material resources, and financial resources in accordance with the high standards required for the formal medical device production license. The total investment is 100 million yuan, equipped with a production plant of 18000 square meters and a purification workshop of 2000 square meters, to comprehensively build a modern first-class and second-class medical device production base.
